Randomized, double-blinded, phase 2 trial of wr 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in panama

American Journal of Tropical Medicine and Hygiene

Volumn 89, Issue 3, 2013, Pages 557-563

  Sosa, Néstor ^a,b,c,d,e   Capitán, Zeuz ^a,b,c,d,e   Nieto, Javier ^a,b,c,d,e   Nieto, Melissa ^a,b,c,d,e   Calzada, José ^a,b,c,d,e   Paz, Hector ^a,b,c,d,e   Spadafora, Carmenza ^a,b,c,d,e   Kreishman Deitrick, Mara ^a,b,c,d,e   Kopydlowski, Karen ^a,b,c,d,e   Ullman, Diane ^a,b,c,d,e   McCarthy, William F ^a,b,c,d,e   Ransom, Janet ^a,b,c,d,e   Berman, Jonathan ^a,b,c,d,e   Scott, Charles ^a,b,c,d,e   Grogl, Max ^a,b,c,d,e  

^a Instituto Conmemorativo Gorgas de Estudios de la Salud   (Panama)

^b INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^c US Army Medical Materiel Development Activity   (United States)

^d Fast Track Drugs and Biologies LLC   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; PAROMOMYCIN; UNCLASSIFIED DRUG; WR 279396;

ADOLESCENT; ADULT; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PAIN; APPLICATION SITE REACTION; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTACT DERMATITIS; CREAM; CREATININE BLOOD LEVEL; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LEISHMANIA PANAMENSIS; MALE; MIGRAINE; MONOTHERAPY; PANAMA; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; SCHOOL CHILD; SKIN LEISHMANIASIS; SKIN ULCER; SPECIES IDENTIFICATION; TOPICAL TREATMENT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; FEMALE; GENTAMICINS; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; PANAMA; PAROMOMYCIN;

EID: 84886885684     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0736     Document Type: Article

References (29)

1. WHO, 2010. Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010.WHOTechnical Report Series 949.
2. University of Texas Southwestern Medical Center, 2008. Dermatologists Identify North Texas Leishmaniasis Outbreak. New Release DALLAS-September 14, 2007. Available at: http://www.utsouthwestern.edu/utsw/cda/dept353744/files/ 411952.html. Accessed 15 August 2012.
3. Pehoushek JE, Quinn DM, Crum WP, 2004. Cutaneous leishmaniasis in soldiers returning from deployment to Iraq. J Am Acad Dermatol 51: S125-S128.
4. Bern C, Maguire JH, Alvar J, 2008. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2: e313.
5. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK, 2007. Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med 356: 2571-2581. (Pubitemid 46961002)
6. Murray HW, Berman JD, Davies CR, Saravia NG, 2005. Advances in leishmaniasis. Lancet 366: 1561-1577. (Pubitemid 41540115)
7. Gonzalez U,Pinart M,Rengifo-PardoM,MacayaA,Alvar J,Tweed JA, 2009. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst RevCD004834.
8. Gonzalez U, Pinart M, Reveiz L, Alvar J, 2008. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev CD005067.
9. Grogl M, Schuster BG, Ellis WY, Berman JD, 1999. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. J Parasitol 85: 354-359. (Pubitemid 29251857)
10. Ben Salah A, Buffet PA, Morizot G, Ben Massoud N, Zâatour A, Ben Alaya N, Haj Hamida NB, El Ahmadi Z, Downs MT, Smith PL, Dellagi K, Gro? gl M, 2009. WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study. PLoS Negl Trop Dis 3: e432.
11. Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ben Ismail R, 1995. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am J Trop Med Hyg 53: 162-166.
12. de Brujin MH, Labrada LA, Smyth AJ, Santrich C, Barker DC, 1993. A comparative study of diagnosis by the polymerase chain reaction and by current clinical methods using biopsies from Colombian patients with suspected leishmaniasis. Trop Med Parasitol 44: 201-207. (Pubitemid 23308067)
13. Vergel C, Walker J, Saravia NG, 2005. Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction. Am J Trop Med Hyg 72: 423-429. (Pubitemid 41278852)
14. Reithinger R, Dujardin JC, 2007. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol 45: 21-25. (Pubitemid 46106401)
15. Garra G, Singer AJ, Taira BR, Chohan J, Cardoz H, Chisena E, Thode HC Jr., 2010. Validation of the Wong-Baker FACES Pain Rating Scale in pediatric emergency department patients. Acad Emerg Med 17: 50-54.
16. Campbell I, 2007. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med 26: 3661-3675. (Pubitemid 47180703)
17. Lydersen S, Fagerland MW, Laake P, 2009. Recommended tests for association in 2 +2 tables. Stat Med 28: 1159-1175.
18. Daneshvar H, Burchmore R, Hagan P, Phillips RS, 2009. Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major. Parasitology 136: 1243-1250.
19. Daneshvar H, Hagan P, Phillips RS, 2003. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice. Parasite Immunol 25: 589-596. (Pubitemid 38445402)
20. Daneshvar H, Molaei MM, Kamiabi H, Burchmore R, Hagan P, Stephen Phillips R, 2010. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis. Parasite Immunol 32: 722-730.
21. Soto J, Fuya P, Herrera R, Berman J, 1998. Topical paromomycin/ methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis 26: 56-58. (Pubitemid 28068155)
22. Arana BA, Mendoza CE, Rizzo NR, Kroeger A, 2001. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg 65: 466-470. (Pubitemid 33134578)
23. Soto-Mancipe J, Grogl M, Berman JD, 1993. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis inColombia. Clin Infect Dis 16: 417-425. (Pubitemid 23066954)
24. Velez I, Agudelo S, Hendrickx E, Puerta J, Grogl M, Modabber F, Berman J, 1997. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med 126: 232-236. (Pubitemid 27061579)
25. Martinez S, Marr JJ, 1992. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 326: 741-744.
26. Lopez-Jaramillo P, Rincon MY, Garcia RG, Silva SY, Smith E, Kampeerapappun P, García C, Smith DJ, Ló pez M, Vé lez ID, 2010. A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis. Am J Trop Med Hyg 83: 97-101.
27. Garnier T, Croft SL, 2002. Topical treatment for cutaneous leishmaniasis. Curr Opin Investig Drugs 3: 538-544.
28. El-Sayed M, Anwar AE, 2009. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. J Eur Acad Dermatol Venereol 24: 335-340.
29. Willard RJ, Jeffcoat AM, Benson PM, Walsh DS, 2005. Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options. J Am Acad Dermatol 52: 977-987. (Pubitemid 40740209)